SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-210938
Filing Date
2013-05-09
Accepted
2013-05-09 16:00:25
Documents
13
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d508095d10q.htm 10-Q 465701
2 EX-10.1 d508095dex101.htm EX-10.1 48456
3 EX-12.1 d508095dex121.htm EX-12.1 38644
4 EX-31.1 d508095dex311.htm EX-31.1 9625
5 EX-31.2 d508095dex312.htm EX-31.2 9560
6 EX-32.1 d508095dex321.htm EX-32.1 3747
7 EX-32.2 d508095dex322.htm EX-32.2 3747
  Complete submission text file 0001193125-13-210938.txt   3169637

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT omer-20130331.xml EX-101.INS 346086
9 XBRL TAXONOMY EXTENSION SCHEMA omer-20130331.xsd EX-101.SCH 32456
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE omer-20130331_cal.xml EX-101.CAL 38978
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omer-20130331_def.xml EX-101.DEF 184997
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE omer-20130331_lab.xml EX-101.LAB 275959
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omer-20130331_pre.xml EX-101.PRE 217223
Mailing Address 201 ELLIOT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOT AVENUE WEST SEATTLE WA 98119 206.676.5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34475 | Film No.: 13828545
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences